SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-094044
Filing Date
2022-08-24
Accepted
2022-08-24 16:30:40
Documents
13
Period of Report
2022-08-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2224097d3_8k.htm   iXBRL 8-K 27480
2 EXHIBIT 5.1 tm2224097d3_ex5-1.htm EX-5.1 5925
  Complete submission text file 0001104659-22-094044.txt   208867

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agrx-20220822.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agrx-20220822_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agrx-20220822_pre.xml EX-101.PRE 22613
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2224097d3_8k_htm.xml XML 3611
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 221191930
SIC: 2834 Pharmaceutical Preparations